Clinical Trials Directory

Trials / Unknown

UnknownNCT03141619

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Dr. Gordon Boyd · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to test the hypothesis that poor cerebral perfusion during critical illness is a risk factor for acute and long-term neurological dysfunction among survivors. We use near-infrared spectroscopy to measure brain tissue oxygenation as a non-invasive surrogate marker for cerebral perfusion. Acute neurological dysfunction is defined as the presence of delirium, which is assessed using the Confusion Assessment Method-Intensive Care Unit (CAM-ICU). Chronic neurological dysfunction is defined as having quantitative impairments on robotic testing (KINARM robot) and traditional neuropsychological screening (Repeatable Battery for the Assessment of Neuropsychological Status).

Conditions

Timeline

Start date
2017-10-13
Primary completion
2024-06-01
Completion
2025-06-01
First posted
2017-05-05
Last updated
2023-12-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03141619. Inclusion in this directory is not an endorsement.